Last10K.com

Kazia Therapeutics Ltd (1075880) SEC Filing 20-F Annual report for the fiscal year ending Saturday, June 30, 2018

Kazia Therapeutics Ltd

CIK: 1075880

View differences made from one year to another to evaluate Kazia Therapeutics Ltd's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Kazia Therapeutics Ltd.

Continue

Assess how Kazia Therapeutics Ltd's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Kazia Therapeutics Ltd's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 20-F Annual Report

Document And Entity Information
Consolidated Statements Of Cash Flows
Consolidated Statements Of Financial Position
Consolidated Statements Of Profit Or Loss And Other Comprehensive Income
Statements Of Changes In Equity
Business Combinations
Business Combinations (Tables)
Business Combinations - Additional Information (Detail)
Business Combinations - Summary Of Details Of Acquisition (Detail)
Business Combinations - Summary Of Range Of Outcomes Of Contingent Consideration (Detail)
Commitments
Commitments (Tables)
Commitments - Additional Information (Detail)
Commitments - Summary Of Lease Commitments - Operating (Detail)
Contingent Consideration
Contingent Consideration (Tables)
Contingent Liabilities
Contingent Liabilities - Additional Information (Detail)
Critical Accounting Judgements, Estimates And Assumptions
Current Assets - Cash And Cash Equivalents
Current Assets - Cash And Cash Equivalents (Tables)
Current Assets - Cash And Cash Equivalents - Summary Of Cash And Cash Equivalents (Detail)
Current Assets - Income Tax Refund Due
Current Assets - Income Tax Refund Due (Tables)
Current Assets - Income Tax Refund Due - Summary Of Current Assets - Income Tax Refund Due (Detail)
Current Assets - Other
Current Assets - Other (Tables)
Current Assets - Other - Summary Of Current Assets - Other (Detail)
Current Assets - Trade And Other Receivables
Current Assets - Trade And Other Receivables (Tables)
Current Assets - Trade And Other Receivables - Additional Information (Detail)
Current Assets - Trade And Other Receivables - Summary Of Ageing Of Impaired Receivables (Detail)
Current Assets - Trade And Other Receivables - Summary Of Current Assets - Trade And Other Receivables (Detail)
Current Liabilities - Contingent Consideration - Summary Of Current Liabilities - Contingent Consideration (Detail)
Current Liabilities - Provisions - Summary Of Current Liabilities - Provisions (Detail)
Current Liabilities - Trade And Other Payables - Summary Of Current Liabilities - Trade And Other Payables (Detail)
Deed Of Cross Guarantee
Deed Of Cross Guarantee - Additional Information (Detail)
Earnings Per Share
Earnings Per Share (Tables)
Earnings Per Share - Additional Information (Detail)
Earnings Per Share - Summary Of Earnings Per Share (Detail)
Equity - Contributed Equity
Equity - Contributed Equity (Tables)
Equity - Contributed Equity - Additional Information (Detail)
Equity - Contributed Equity - Summary Of Equity - Contributed Equity (Detail)
Equity - Contributed Equity - Summary Of Movements In Ordinary Share Capital (Detail)
Equity - Contributed Equity - Summary Of Movements In Ordinary Share Capital (Parenthetical) (Detail)
Equity - Dividends
Equity - Dividends - Additional Information (Detail)
Equity - Other Contributed Equity
Equity - Other Contributed Equity (Tables)
Equity - Other Contributed Equity - Additional Information (Detail)
Equity - Other Contributed Equity - Summary Of Equity -Other Contributed Equity (Detail)
Equity - Reserves
Events After The Reporting Period
Events After The Reporting Period - Additional Information (Detail)
Expenses
Expenses (Tables)
Expenses - Summary Of Expenses (Detail)
Fair Value Measurement
Fair Value Measurement (Tables)
Fair Value Measurement - Additional Information (Detail)
Fair Value Measurement - Summary Of Assets And Liabilities, Measured Or Disclosed At Fair Value (Detail)
Financial Instruments
Financial Instruments (Tables)
Financial Instruments - Additional Information (Detail)
Financial Instruments - Summary Of Foreign Currency Risk (Detail)
Financial Instruments - Summary Of Foreign Currency Risk Sensitivity (Detail)
Financial Instruments - Summary Of Remaining Contractual Maturities Of Financial Instrument Liabilities (Detail)
Financial Instruments - Summary Of Variable Interest Rate Balances (Detail)
General Information
Income Tax Benefit
Income Tax Benefit (Tables)
Income Tax Benefit - Summary Of Income Tax Benefit (Detail)
Income Tax Benefit - Summary Of Income Tax Benefit (Parenthetical) (Detail)
Interests In Subsidiaries
Interests In Subsidiaries (Tables)
Interests In Subsidiaries - Summary Of Interest In Subsidiaries (Detail)
Key Management Personnel Disclosures
Key Management Personnel Disclosures (Tables)
Key Management Personnel Disclosures - Summary Of Compensation Made To Directors And Other Members Of Key Management Personnel (Detail)
Non-Current Assets - Financial Assets
Non-Current Assets - Financial Assets (Tables)
Non-Current Assets - Financial Assets - Summary Of Non-Current Assets - Financial Assets (Detail)
Non-Current Assets - Intangibles
Non-Current Assets - Intangibles (Tables)
Non-Current Assets - Intangibles - Summary Of Non-Current Assets - Intangibles (Detail)
Non-Current Assets - Intangibles - Summary Of Reconciliations Of Intangibles (Detail)
Non-Current Assets - Property, Plant And Equipment
Non-Current Assets - Property, Plant And Equipment (Tables)
Non-Current Assets - Property, Plant And Equipment - Summary Of Non-Current Assets - Property, Plant And Equipment (Detail)
Non-Current Assets - Property, Plant And Equipment - Summary Of Reconciliations Of Property, Plant And Equipment (Detail)
Non-Current Liabilities - Contingent Consideration - Summary Of Non-Current Liabilities - Contingent Consideration (Detail)
Non-Current Liabilities - Deferred Tax
Non-Current Liabilities - Deferred Tax (Tables)
Non-Current Liabilities - Deferred Tax - Summary Of Non-Current Liabilities - Deferred Tax (Detail)
Operating Segments
Operating Segments - Additional Information (Detail)
Other Income
Other Income (Tables)
Other Income - Summary Of Other Income (Detail)
Parent Entity Information
Parent Entity Information (Tables)
Parent Entity Information - Additional Information (Detail)
Parent Entity Information - Statement Of Financial Position (Detail)
Parent Entity Information - Statement Of Profit Or Loss And Other Comprehensive Income (Detail)
Provisions
Provisions (Tables)
Related Party Transactions
Related Party Transactions (Tables)
Related Party Transactions - Additional Information (Detail)
Related Party Transactions - Summary Of Transactions Occurred With Related Parties (Detail)
Remuneration Of Auditors
Remuneration Of Auditors (Tables)
Remuneration Of Auditors - Summary Of Remuneration Of Auditors (Detail)
Revenue
Revenue (Tables)
Revenue - Summary Of Revenue (Detail)
Settlement Of Legal Proceedings
Settlement Of Legal Proceedings - Additional Information (Detail)
Share-Based Payments
Share-Based Payments (Tables)
Share-Based Payments - Additional Information (Detail)
Share-Based Payments - Summary Of Share-Based Payments (Detail)
Share-Based Payments - Summary Of Valuation For Each Tranche Of Options (Detail)
Significant Accounting Policies
Significant Accounting Policies (Policies)
Significant Accounting Policies - Additional Information (Detail)
Trade And Other Payables
Trade And Other Payables (Tables)
CIK: 1075880
Form Type: 20-F Annual Report
Accession Number: 0001193125-18-305893
Submitted to the SEC: Wed Oct 24 2018 7:22:50 AM EST
Accepted by the SEC: Wed Oct 24 2018
Period: Saturday, June 30, 2018
Industry: Pharmaceutical Preparations

External Resources:

Bookmark the Permalink:
https://last10k.com/sec-filings/1075880/0001193125-18-305893.htm